Search
Viridian Therapeutics Inc
VRDNAdd to Watchlist
21.430USD
-0.690-3.12%
Close 09-23 16:00（ET）
2.37BMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-3.12%
5 Days
-4.50%
1 Month
-11.77%
6 Months
-22.41%
Year to Date
-31.14%
1 Year
+9.56%
Key Figures
22.110Open
22.185High
250.76KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.23%Turnover Ratio
22.120Prev. Close
21.200Low
5.38MTurnover
LossP/E Static
4.19P/B
0.00%Div Yield TTM
-49.74%ROA
34.29052wk High
42.43Volume Ratio
-269.95MNet Profit
110.43MShares
-3.9978EPS TTM
1.21Beta
-78.43%ROE
13.18052wk Low
5.06%Amplitude
100.00%Gross Margin
2.37BMarket Cap
5.81Reward/Risk
4.51%Risk Rate
More news coming soon, stay tuned...
Viridian Therapeutics Inc's Score
-0.06vs previous score
Forecast8.71
Financial Health6.59
Technical3.25
Valuation Dimensions7.30
Institutional Confidence10.00
Risk Assessment5.93
Media Coverage
Coverage Level
Very Low
Very High
Negative-
Analyst Rating
Viridian Therapeutics Inc Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Strong sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-1.18/-1.03
Revenue / Forecast
284.00K/22.31K
Viridian Therapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolVRDN
Number of employees143
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Fidelity Management & Research Company LLC | 11.24% |
| BlackRock Institutional Trust Company, N.A. | 5.03% |
| Deep Track Capital LP | 4.91% |
| Bellevue Asset Management AG | 3.95% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 41.90% |
| Hedge Fund | 24.54% |
| Investment Advisor/Hedge Fund | 21.23% |
| Venture Capital | 7.32% |
Related Instruments
-1.64%
-0.01%
-0.05%
-1.88%
+1.01%
-2.99%
-1.01%
-0.85%
-3.12%
+0.90%
+0.26%
-1.77%
-1.20%
-2.00%
-1.99%
-0.26%
-0.25%
-0.74%
-1.86%
-0.35%Popular Instruments
51383.700
-106.300 (-0.21%)
30307.000
-170.900 (-0.56%)
7677.700
-29.300 (-0.38%)
14265.000
-157.000 (-1.09%)
65700.000
-429.000 (-0.65%)
6270.300
-19.700 (-0.31%)
92.053
-0.437 (-0.47%)
337.020
-2.730 (-0.80%)
225.510
-3.360 (-1.47%)
4284.630
-1.610 (-0.04%)
FAQs
What is the current price of Viridian Therapeutics Inc (VRDN)?
The current price of Viridian Therapeutics Inc (VRDN) is 21.43.
What is the symbol of Viridian Therapeutics Inc?
The ticker symbol of Viridian Therapeutics Inc is VRDN.
What is the 52-week high of Viridian Therapeutics Inc?
The 52-week high of Viridian Therapeutics Inc is 34.29.
What is the 52-week low of Viridian Therapeutics Inc?
The 52-week low of Viridian Therapeutics Inc is 13.18.
What is the market capitalization of Viridian Therapeutics Inc?
The market capitalization of Viridian Therapeutics Inc is 2.37B.
Is Viridian Therapeutics Inc (VRDN) currently rated as Buy, Hold, or Sell?
According to analysts, Viridian Therapeutics Inc (VRDN) has an overall rating of Buy, with a price target of 36.20.
What is the Earnings Per Share (EPS TTM) of Viridian Therapeutics Inc (VRDN)?
The Earnings Per Share (EPS TTM) of Viridian Therapeutics Inc (VRDN) is -4.00.